1. Home
  2. MDBH vs CRVO Comparison

MDBH vs CRVO Comparison

Compare MDBH & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDB Capital Holdings LLC common

MDBH

MDB Capital Holdings LLC common

N/A

Current Price

$3.19

Market Cap

36.5M

Sector

N/A

ML Signal

N/A

Logo CervoMed Inc.

CRVO

CervoMed Inc.

N/A

Current Price

$2.94

Market Cap

35.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MDBH
CRVO
Founded
1997
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.5M
35.9M
IPO Year
2022
2011

Fundamental Metrics

Financial Performance
Metric
MDBH
CRVO
Price
$3.19
$2.94
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$23.00
AVG Volume (30 Days)
4.1K
64.7K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,006,510.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.75
$2.82
52 Week High
$5.50
$13.13

Technical Indicators

Market Signals
Indicator
MDBH
CRVO
Relative Strength Index (RSI) 42.20 36.82
Support Level $3.08 $2.82
Resistance Level $3.20 $4.20
Average True Range (ATR) 0.21 0.19
MACD -0.08 0.00
Stochastic Oscillator 19.00 29.67

Price Performance

Historical Comparison
MDBH
CRVO

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The company operates in two reportable segments: a broker dealer & intellectual property service; and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: